Emapalumab-Lzsg 10 mg/2 mL, 50 mg/10 mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 10 mg/2 mL, 50 mg/10 mL
Reference Brands: Gamifant (USA/EU)
Category: Orphan Drugs
Emapalumab-lzsg is a fully human monoclonal antibody that binds and neutralizes interferon-gamma (IFN-γ), helping to suppress excessive immune activation. It is used in patients with hemophagocytic lymphohistiocytosis (HLH), a rare and life-threatening hyperinflammatory syndrome. By inhibiting IFN-γ activity, it helps restore immune balance in patients unresponsive or intolerant to conventional treatments such as corticosteroids, etoposide, or cyclosporine.
Emapalumab-Lzsg — third party manufacturing & bulk supply
Emapalumab-Lzsg 10 mg/2 mL, 50 mg/10 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Emapalumab-Lzsg listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Emapalumab-Lzsg →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Emapalumab-lzsg is used to treat primary hemophagocytic lymphohistiocytosis (HLH) in adults and children who have not responded to conventional therapy. It helps control excessive immune activation by blocking interferon gamma, a key inflammatory cytokine involved in the disease.
Emapalumab-lzsg is made from the active ingredient emapalumab-lzsg, a recombinant human monoclonal antibody that specifically binds to and neutralizes interferon gamma, reducing the severe inflammation and immune system overactivity seen in HLH.
Emapalumab-lzsg is marketed under the trade name Gamifant.
Emapalumab-lzsg is manufactured by Sobi (Swedish Orphan Biovitrum AB).
The generic name of Emapalumab-lzsg is Emapalumab-lzsg.
The brand name of Emapalumab-lzsg is Gamifant.
Emapalumab-lzsg is manufactured in the United States and Sweden by Sobi (Swedish Orphan Biovitrum AB) and its authorized production partners.
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
